Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Bell

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Human Factors|April 15, 2020
In Situ Tremor in Vitreoretinal SurgeryYifan Li, Mitchell D Wolf, Amol D Kulkarni, et al.
Drug and Alcohol Dependence|May 14, 2011
Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosingBriony Larance, Louisa Degenhardt, Nick Lintzeris, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 1, 2017
Compact radioactive aerosol monitoring device for early warning networksDenis Glavič-Cindro, Drago Brodnik, Toni Petrovič, et al.
Therapeutic Innovation & Regulatory Science|February 20, 2020
Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) GuidelinesBohdana Ratitch, Niti Goel, Craig Mallinckrodt, et al.
AIDS Care|February 21, 2009
Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disordersClaude Ann Mellins, Jennifer F Havens, Cheryl McDonnell, et al.
Therapeutic Innovation & Regulatory Science|February 20, 2020
Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into PracticeBohdana Ratitch, James Bell, Craig Mallinckrodt, et al.
Pharmaceutical Statistics|March 6, 2025
Estimation Methods for Estimands Using the Treatment Policy Strategy; a Simulation Study Based on the PIONEER 1 TrialJames Bell, Thomas Drury, Tobias Mütze, et al.
European Addiction Research|March 8, 2017
Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety StudyJohn Strang, Kylie Reed, Karolina Bogdanowicz, et al.
Journal of the Royal Society, Interface|June 9, 2017
The structural response of the cornea to changes in stromal hydrationSally Hayes, Tomas White, Craig Boote, et al.
Drug and Alcohol Dependence|June 25, 2003
Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductionsCourtney L Breen, Simon J Harris, Nicholas Lintzeris, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Human Factors|April 15, 2020
In Situ Tremor in Vitreoretinal SurgeryYifan Li, Mitchell D Wolf, Amol D Kulkarni, et al.
Drug and Alcohol Dependence|May 14, 2011
Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosingBriony Larance, Louisa Degenhardt, Nick Lintzeris, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 1, 2017
Compact radioactive aerosol monitoring device for early warning networksDenis Glavič-Cindro, Drago Brodnik, Toni Petrovič, et al.
Therapeutic Innovation & Regulatory Science|February 20, 2020
Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) GuidelinesBohdana Ratitch, Niti Goel, Craig Mallinckrodt, et al.
AIDS Care|February 21, 2009
Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disordersClaude Ann Mellins, Jennifer F Havens, Cheryl McDonnell, et al.
Therapeutic Innovation & Regulatory Science|February 20, 2020
Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into PracticeBohdana Ratitch, James Bell, Craig Mallinckrodt, et al.
Pharmaceutical Statistics|March 6, 2025
Estimation Methods for Estimands Using the Treatment Policy Strategy; a Simulation Study Based on the PIONEER 1 TrialJames Bell, Thomas Drury, Tobias Mütze, et al.
European Addiction Research|March 8, 2017
Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety StudyJohn Strang, Kylie Reed, Karolina Bogdanowicz, et al.
Journal of the Royal Society, Interface|June 9, 2017
The structural response of the cornea to changes in stromal hydrationSally Hayes, Tomas White, Craig Boote, et al.
Drug and Alcohol Dependence|June 25, 2003
Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductionsCourtney L Breen, Simon J Harris, Nicholas Lintzeris, et al.
Pageof 13